Good Fellow Healthcare Holdings Limited Stocks

HK$ 0.12Last Updated 25.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

HK$ 16.56M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
HK$ 0.12
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Good Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.

Company Valuation

Greatly overvalued
1/7

Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overpriced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks